Clinical Trial: INVESTIGATION of the EFFICACY and SAFETY of the DRUG "AS-PROBIONORM"

U.S., March 21 -- ClinicalTrials.gov registry received information related to the study (NCT06886399) titled 'INVESTIGATION of the EFFICACY and SAFETY of the DRUG "AS-PROBIONORM"' on March 13.

Brief Summary: The subject of this clinical trial is the medicine "AS-Probionorm". Pharmacological group - Antidiarrheal drugs. Antidiarrheal microorganisms. Microorganisms that produce lactic acid.

The investigational probiotic medicine "AS-Probionorm" was created on the basis of an association of lactic acid bacteria with targeted action for oral use for the treatment of inflammatory and infectious diseases of the human gastrointestinal tract.

The second phase of a clinical trial is the study of a medicine conducted on volunteers to establish eff...